How immunocompromised are short bowel patients receiving home parenteral nutrition? apropos a case of disseminated fusarium oxysporum sepsis

Journal of Parenteral and Enteral Nutrition

Volumn 33, Issue 6, 2009, Pages 717-720

  Müller, Christoph ^a   Schumacher, Ulrike ^a   Gregor, Michael ^a   Lamprecht, Georg ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Catheter related sepsis; Fusarium oxysporum; Home parenteral nutrition; Short bowel syndrome; Voriconazole

Indexed keywords

ALBUMIN; FLUCLOXACILLIN; VORICONAZOLE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASPLENIA; BLOOD CULTURE; BONE MARROW BIOPSY; CASE REPORT; CATHETER INFECTION; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; ESOPHAGOJEJUNOSTOMY; FEMALE; FEVER; FUNGEMIA; FUSARIUM OXYSPORUM; HEMATOLOGIC DISEASE; HOME CARE; HUMAN; HYPERPHAGIA; IMMUNOCOMPROMISED PATIENT; INSULIN DEPENDENT DIABETES MELLITUS; LEG EDEMA; LUNG INFILTRATE; PANCREAS RESECTION; PANCREATICOJEJUNOSTOMY; PARENTERAL NUTRITION; PRIORITY JOURNAL; SHORT BOWEL SYNDROME; SKIN ULCER; SPLENECTOMY; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS INFECTION; THORAX RADIOGRAPHY; TRANSVERSE COLON; TREATMENT DURATION; TREATMENT RESPONSE;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CATHETERIZATION; DIABETES MELLITUS, TYPE 1; EQUIPMENT CONTAMINATION; FEMALE; FLOXACILLIN; FUSARIUM; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED; PARENTERAL NUTRITION, HOME; PYRIMIDINES; SEPSIS; SHORT BOWEL SYNDROME; SPLEEN; TRIAZOLES;

BACTERIA (MICROORGANISMS); CANDIDA; FUSARIA; FUSARIUM; FUSARIUM OXYSPORUM; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 70449503886     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607109346321     Document Type: Article

References (17)

1. Howard L., Ashley C. Management of complications in patients receiving home parenteral nutrition. Gastroenterology. 2003 ; 124: 1651-1661.
2. Fishbein TM, Matsumoto CS Intestinal replacement therapy: timing and indications for referral of patients to an intestinal rehabilitation and transplant program. Gastroenterology. 2006 ; 130: S147 - S151.
3. Kono K., Sekikawa T., Iizuka H., et al. T-cell dysfunction in a patient with short bowel syndrome: report of a case. Surg Today. 1999 ; 29: 1253-1256.
4. Hise ME, Compher C., Harlan L., et al. Inflammatory mediators and immune function are altered in home parenteral nutrition patients. Nutrition. 2006 ; 22: 97-103.
5. Sun X., Yang H., Nose K., et al. Decline in intestinal mucosal IL-10 expression and decreased intestinal barrier function in a mouse model of total parenteral nutrition. Am J Physiol. 2008 ; 294: G139 - G147.
6. Yang H., Sun X., Haxhija EQ, Teitelbaum DH Intestinal epithelial cell-derived interleukin-7: a mechanism for the alteration of intraepithelial lymphocytes in a mouse model of total parenteral nutrition. Am J Physiol. 2007 ; 292: G84 - G91.
7. Ziegler TR, Luo M., Estivariz CF, et al. Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome. Am J Physiol. 2008 ; 294: R402 - R410.
8. Nucci M., Anaissie E. Emerging fungi. Infect Dis Clin North Am. 2006 ; 20: 563-579.
9. Nucci M., Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007 ; 20: 695-704.
10. Nucci M., Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis. 2002 ; 35: 909-920.
11. Al Abdely HM Management of rare fungal infections. Curr Opin Infect Dis. 2004 ; 17: 527-532.
12. Johnson LB, Kauffman CA Voriconazole: a new triazole antifungal agent. Clin Infect Dis. 2003 ; 36: 630-637.
13. Walsh TJ, Pappas P., Winston DJ, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002 ; 346: 225-234. (Pubitemid 34438861)
14. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect. 2004 ; 10 (suppl 1). 67-75.
15. Nelson PE, Dignani MC, Anaissie EJ Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev. 1994 ; 7: 479-504.
16. Perez-Perez L., Pereiro M., Sanchez-Aguilar D., Toribio J. Ulcerous lesions disclosing cutaneous infection with Fusarium solani. Acta Derm Venereol. 2007 ; 87: 422-424.
17. Nucci M., Marr KA, Queiroz-Telles F., et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2004 ; 38: 1237-1242.